Pharmafile Logo

Cheers to 10 years!

March 7, 2017 |  

Lucid Group celebrate their 10th birthday in style

- PMLiVE
Last Thursday, it was cocktail o’clock for the Lucid UK team in celebration of the company’s 10th birthday! With live saxophone music and bespoke drinks, Lucid Group toasted to 10 exceptional years of changing lives though pioneering medical education. Celebrations in the US office followed this Wednesday, with a smaller crowd but certainly no less exuberant. Since its conception in 2007, Lucid has grown from its two co-founders, Dennis O’Brien (CEO) and Jan Steele (COO), to more than 100 employees in four offices across the UK and USA. Over the past 10 years, the agency has delivered over 3,000 behaviour-change programmes, reached over 50,000 healthcare providers worldwide, and changed over 25 million patients’ lives. Numerous Communiqué Awards and PMEA Awards speak to the far-reaching success of Lucid’s approach.

Jan Steele commented “We have come so far since we started Lucid in 2007. Our ongoing success demonstrates that there is a sustained need for medical education programmes that change patient outcomes. None of this would have been possible without the hard work of our Lucid team, which includes some of the brightest people in the industry. It has been a truly exhilarating ride and I can’t wait to see what comes next!”

However, Lucid’s work is not done yet. In the coming months and years, the agency is planning to rollout brand new tools to widen the reach and measure the impact of their initiatives, which will help to create even more precisely tailored programmes. With that in mind, cheers to the next 10 years of changing patient’s lives through medical education!

You can learn more about Lucid at www.lucid-group.co.uk 
- PMLiVE

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid team : because you’re worth it!

Lucid group reward the team for an amazing year

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education